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ABSTRACT
Background and objectives: Although it is accepted that
reﬂux of stomach acid causes gastroesophageal reﬂux dis-
ease (GERD), it is less well understood that it also con-
tributes to the clinical signs and symptoms of laryngitis in
the form of laryngopharyngeal reﬂux (LPR). Study objec-
tives were to identify what is known about the impact of
LPR on health-related quality of life (HRQL) compared
with the impact of GERD on HRQL and to assess
whether currently available HRQL instruments ade-
quately measure this impact or if a new disease-speciﬁc
instrument should be recommended.
Methods: The authors combined a systematic literature
review with prospective patient evaluation via focus
groups. The review, using MEDLINE, focused on clinical
characteristics and HRQL measurement and impact.
Focus groups involving a total of 30 patients with LPR
provided input on clinical manifestations of the disease
and its HRQL impact.
Results: Information gleaned from the literature indicates
that less than 40% of patients presenting with symptoms
of laryngitis directly attributable to reﬂux also report
experiencing the classic symptoms of heartburn and acid
regurgitation associated with GERD. Reﬂux laryngitis is
thus a distinct clinical entity from GERD and may have a
unique impact on HRQL. Although multiple instruments
are available to assess the impact of GERD on HRQL, no
speciﬁc instruments are available for LPR. Focus group
discussions identiﬁed voice problems, chronic cough,
throat clearing, and swallowing difﬁculties to be key con-
cerns of patients with LPR. These manifestations nega-
tively impact HRQL as described by the focus group
participants, notably in role functioning, physical well-
being, and emotional well-being.
Conclusions: A disease-speciﬁc instrument to assess the
impact of LPR on HRQL would contribute to clinical
care and the evaluation of new therapies. This instrument
would ideally be sensitive to the variety of LPR’s symp-
tomatic presentations.
Keywords: extraesophageal reﬂux, laryngopharyngeal
reﬂux, quality of life.
Introduction
The reﬂux of stomach acid into the esophagus has
long been recognized as the cause of gastroesopha-
geal reﬂux disease (GERD). Despite the natural
upward extension of this anatomical link to the lar-
ynx, it was not until 1968 that acid reﬂux was
shown to be a causal factor in laryngitis, now know
as laryngopharyngeal reﬂux (LPR) [1]. Although
acid reﬂux is a common etiologic factor, the signs
and symptoms of disease vary considerably between
GERD and LPR (Table 1). Both conditions cause
signiﬁcant morbidity and in some cases can lead to
more serious complications, such as erosive
esophagitis (EE), Barrett’s esophagus (a precancer-
ous condition), laryngeal stenosis, and leukoplakia.
Because of the high prevalence of GERD and,
possibly, LPR in Western society [2], it is important
to identify overlapping as well as distinct symptoms
of the two conditions. Physicians may overlook the
laryngopharyngeal implications of acid reﬂux when
accompanying acid damage to the lower esophagus
or the symptom of heartburn is absent [2]. Further-
more, the extension of the damaging effects of acid
reﬂux into the laryngeal region coincidentally
occurs in a region of the digestive tract where there
is a “hand off” between two medical subspecialties.
ENTs/otolaryngologists tend to focus above the
esophagus and gastroenterologists below. Medical
issues like reﬂux laryngitis, with etiology and effect
crossing over two zones, are not handled efﬁciently
[3]. Consequently, the true incidence of LPR is not
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well deﬁned and referral to a specialist does not
ensure appropriate therapy [4].
The impact of illness and its treatments on
health-related quality of life (HRQL) would seem to
be important considerations both for patients with
LPR and for their health-care providers [5,6].
Generic and disease-speciﬁc HRQL instruments,
typically validated and demonstrated to be reliable,
can help physicians particularly when the disorder
is chronic in nature and primarily diagnosed on the
basis of symptoms [7–9]. HRQL measures can
quantify treatment effects in ways that are mean-
ingful to patients.
The aims of this article are to: 1) highlight the
differences and similarities between GERD and LPR
with respect to signs and symptoms; 2) show how
the clinical manifestations of GERD affect HRQL
and examine what HRQL domains might apply to
LPR patients; and 3) evaluate the current avail-
ability of HRQL instruments for use in patients
with LPR disease.
Methods
We used a combination of systematic literature
review and patient focus group evaluation for this
initiative. Speciﬁcally, we reviewed the literature
using MEDLINE, focusing on LPR’s clinical char-
acteristics and diagnosis, as well as HRQL measure-
ment and impact. In addition, four focus groups of
patients diagnosed with LPR were conducted to
assess symptom presentation and their impact on
the lives of patients with LPR.
For the literature review, we used the following
search terms and their combinations: “laryn-
gopharyngeal reﬂux,” “gastroesophageal disease,”
“dysphonia,” and “quality of life.” Clinical charac-
teristics and diagnostic issues associated with LPR
were reviewed to understand the distinction be-
tween GERD and LPR as well as to identify any
existing research on the impact of LPR on quality of
life. We hypothesized the impact of LPR on quality
of life using existing theoretical frameworks for
deﬁning HRQL [10,11]. These frameworks empha-
size the multidimensional nature of health-related
quality of life and integrate objective aspects of
health status with subjective phenomena. The
review for potential instruments and scales availa-
ble to assess LPR included a search for both generic
and disease-speciﬁc measures designed to assess
upper GI disease and related manifestations.
Based on this review, we conducted four patient
focus groups to further evaluate the patient-
reported impact of signs and symptoms of LPR on
the daily lives of patients. Thirty patients who were
currently receiving treatment for LPR from one of
two otolaryngology clinics were invited to partici-
pate in the patient focus groups by the otolaryngol-
ogist providing their care. One of the clinics was
community-based while the other was afﬁliated
with a major tertiary care teaching hospital. The
patients ranged from those newly diagnosed with
LPR to those who had been through several treat-
ment cycles over a 2- to 3-year period. One of the
authors (W.R.L.) who is a licensed clinical psychol-
ogist served as the facilitator for all of the focus
groups. A semistructured interview format was
employed with each session being audiotaped for
later review and qualitative analysis. Each session
began with introductions, a discussion of ground
rules for the session, assurance that conﬁdentiality
would be maintained, and a reiteration of the pur-
pose of the discussion. The facilitator introduced
discussion topics, and all participants were encour-
aged to offer their personal experience and perspec-
tives. Participants were initially asked to describe
their own symptoms of LPR, how long they had
been experiencing these symptoms, any day-to-day
Table 1 Characteristic signs and symptoms of GERD and LPR*
Symptom GERD LPR
Heartburn Extremely common Somewhat common
Acid regurgitation Extremely common Extremely common
Epigastric pain Somewhat common Not Usually
Esophageal dysmotility Extremely common Very common
Dysphagia Somewhat common Very common
Asthma Somewhat common Somewhat common
Hoarseness Not usually Extremely common
Chronic cough Not usually Extremely common
Globus sensation Not usually Extremely common
Acid pH pH < 4 in lower esophagus pH < 5 in upper esophagus and pharynx
Inﬂammation and edema Laryngopharyngeal
Attacks triggered by supine position Attacks triggered by upright position
Lower esophageal sphincter dysfunction Both upper and lower esophageal sphincter dysfunction
*Signs and symptoms are rated as to whether they are extremely common, very common, somewhat common, or not usually present [13–17].
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variation in symptom severity, and what things
seemed to trigger their symptoms. The focus group
participants were then asked to comment on how
LPR affected them in the following ways: cause of
emotional distress, impacting energy level, perform-
ing work-related activities, and during social inter-
actions. The facilitator also inquired about the
participants’ perception of themselves as healthy
persons. In closing, the participants were asked
whether there were other aspects of LPR not yet dis-
cussed that were important to them that they would
like to bring up and whether they were comfortable
sharing their feelings on LPR.
The resulting audiotapes from the focus group
sessions were later reviewed and common themes in
responses were identiﬁed. The level of importance
of single issues was evaluated on the basis of the
emotional tone of the speaker who brought up the
issue and the amount of concurrence from other
participants as to similar experiences.
Results
The literature review revealed that patients with
LPR have different patterns of reﬂux than patients
with GERD. This is expressed in symptom presen-
tation, complications, and response to treatment.
The authors of a recently published Position
Statement of the committee on speech, voice, and
swallowing of the American Academy of Otolaryn-
gology–Head and Neck Surgery have summarized
those differences very well [12]. They note that the
most signiﬁcant difference between LPR and GERD
is that the majority of patients with LPR do not
have esophagitis or its primary symptom, heart-
burn. In a number of studies, the reported incidence
of heartburn in LPR patients is less than 40% and
the incidence of erosive esophagitis is approxi-
mately 25%. The authors characterized the differ-
ences in mechanisms as follows: LPR patients are
predominantly upright, daytime reﬂuxers while
GERD patients are predominantly supine, night-
time reﬂuxers; there are prolonged periods of acid
exposure in GERD but not in LPR; and the primary
anatomical defect in GERD is lower esophageal
sphincter dysfunction while for LPR it is upper
esophageal sphincter dysfunction [12].
The most common clinical manifestations of LPR
include hoarseness, chronic cough, throat clearing
and sore throat, globus sensation, and vocal cord
granulomas (Table 1) [13–17]. Other less common
manifestations include buccal burning, halitosis,
otalgia, stridor, and abnormal or loss of taste [17].
Thus, it is not surprising that LPR is a common
underlying cause of voice disorders [18]. LPR has
also been implicated in the development of more
serious complications such as leukoplakia and vocal
cord squamous cell carcinoma, laryngeal stenosis,
intubation granuloma, and aspiration pneumonia
[13]. Many patients with head and neck cancers
also experience symptoms of LPR [19]. Neverthe-
less, the variability of LPR presentation may cause
difﬁculty in diagnosing the condition in conjunction
with these diseases [4].
GERD and HRQL
Published literature indicates that HRQL items of
importance to patients with GERD include bodily
pain, sleep, vitality, work and social function, anx-
iety, mood, and self-control. The HRQL of patients
with GERD has been reported to be worse than that
of patients with other chronic diseases. For exam-
ple, patients with untreated GERD reported worse
pain, social functioning, and emotional well-being
than those with diabetes or hypertension [20]. In
addition, as measured by the Psychological General
Well-Being Index (PGWB), an instrument target-
ing the psychological and emotional domains of
HRQL, untreated patients with GERD reported
more impaired general well-being than patients
with untreated hypertension, mild heart failure, or
angina [21]. Patients with gastrointestinal disorders
also rated the impact of their condition on well-
being, mental health, and functional status as
exceeding that of patients with back problems, dia-
betes, chronic lung problems, hypertension, and
arthritis [22]. While there are multiple disease-
speciﬁc HRQL instruments for GERD available
[5,23], the speciﬁcity of anchor references in the
questions to heartburn and acid regurgitation
reduce their utility in LPR because so few LPR
patients also report having heartburn.
LPR and HRQL
Although there have been no speciﬁc studies on the
impact of LPR on HRQL, the impact of voice dis-
orders on HRQL has been addressed in patient pop-
ulations [24]. Social and occupational factors are
likely to exert a major inﬂuence on patients with
LPR who have voice problems. The more important
voice quality is to an individual in a social or occu-
pational setting, such as for a professional voice
user, for example, a teacher, salesperson, lawyer, or
singer, the more incapacitating can be its symptoms
of hoarseness, chronic cough, or throat clearing.
Symptoms with a major impact on HRQL include
dysphonia in a professional voice user, pachyder-
mia, and chronic cough; the latter can be severe
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enough to be incapacitating at times. Major seque-
lae include dysplasia and granuloma or ulcers. The
impact of these symptoms on the population not so
directly affected relative to their occupation or pro-
fession should also be considered. Voice problems
can adversely affect communication and interac-
tion, and thus self-esteem, in both general occupa-
tional and social settings. Because most occupations
require verbal interaction, the impact of voice prob-
lems may decrease ability to perform one’s func-
tional role, one domain of HRQL. The impact of
psychological factors on HRQL may also be con-
sidered, but the importance of factors such as anx-
iety and depression in LPR speciﬁcally does not
appear to be well studied. Although laryngeal car-
cinoma is rare, patients with any of the common
symptoms of LPR may worry that the symptom
could be an early warning sign of cancer.
Voice and vocal quality are part of a person’s
identity and our judgments of others may be inﬂu-
enced by these characteristics. Thus vocal problems
can precipitate negative psychological, emotional,
and social consequences for affected individuals.
The Voice Handicap Index (VHI) is the only instru-
ment that has been validated for assessing the
impact of voice disorders on HRQL [24]. Although
patients with voice disorders overlap with the LPR
population, these patients also have problems not
typically associated with LPR, including vocal fold
paralysis, and spasmodic dysphonia. Researchers
concluded that the HRQL impact associated with
voice disorders is greater than expected based on
the speciﬁc functional limitations associated with
the voice disorder [25]. These results are similar to
those found in patients with GERD, who had sig-
niﬁcantly worse scores on all eight dimensions
measured by the SF-36 when compared with the
general US population [20]. Thus, it is reasonable to
expect that a similar negative impact on HRQL may
also occur in patients with LPR.
Based on the literature review, the authors
hypothesized that the greatest impact of LPR is
likely to be in the area of social functioning,
although emotional and psychological well-being
and role performance might also be signiﬁcantly
affected. The patient focus groups were structured
to investigate whether these hypothesized con-
structs of HRQL were affected by LPR.
Four key symptom complaints were identiﬁed
that affected LPR patients in the focus groups: voice
problems, chronic cough, throat clearing, and swal-
lowing difﬁculties. These were major concerns for
these patients, primarily in the context of social
and occupational environments. Based on feedback
from the patients, these LPR symptoms appear to
lead to substantial psychological, emotional, and
social problems. Signiﬁcantly, their negative impact
on self-esteem and relationships was pronounced.
Fatigue, frustration, strain, and generally increased
stress levels all appear to contribute to a lower
HRQL in these patients. The reader can see this
illustrated in quotes from the focus group partici-
pants, which are summarized in Table 2.
Conclusions
The medical literature and patient focus groups
have yielded a variety of clinical and HRQL-related
information that provides a better, though prelimi-
nary, understanding of the major HRQL impact of
LPR. This is aided by a more comprehensive under-
standing of: 1) the similarities and differences
between GERD and LPR; and 2) the comparable
diagnoses and symptoms, e.g., voice disorders. The
literature and the focus groups have helped to iden-
tify: 1) key drivers of patient-perceived burden, such
as signs and symptoms; and 2) key HRQL domains
that seem to be most adversely affected. These in
turn could serve as the basis for a new LPR HRQL
instrument.
Table 2 Patient descriptions of the impact of LPR sorted by probe topics used by the focus group facilitator
Social functioning Psychological Emotional well-being Role performance
Meeting new people has
become difﬁcult.
It’s frustrating when you can’t
speak and make yourself
understood.
I don’t feel sick but people 
ask if I am sick when they
hear me coughing.
My raspy voice gives the wrong
impression that I am upset or
being harsh toward others.
Can’t go places where
quiet is expected (church,
movies) because of 
the coughing.
I’m anxious about permanently
losing my voice.
Coughing takes a lot of
energy out of me.
Had to resign my position as 
music minister at my church.
Don’t take as active a role
in social situations; feel
inhibited in conversations.
I was embarrassed when a coworker
told me they could recognize me
by my cough.
It’s not just what you say but how
you say it to get others to do
things. My hoarseness handicaps
me.
Afraid to eat because of feeling of
lump in throat.
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Overall, LPR is an atypical manifestation of acid
reﬂux that is characterized by hoarseness, chronic
cough, excessive phlegm leading to chronic throat
clearing, difﬁculty in swallowing, and laryngos-
pasm. Although most individuals with LPR symp-
toms do not have the classic heartburn symptom of
GERD, there are some commonalities between the
two disorders in regard to cause and treatment. As
with many chronic illnesses, LPR can have a minor,
major, or life-threatening impact on an individual.
The extent of disruption of HRQL depends upon
the type and severity of symptoms experienced,
and partly on factors extrinsic to the disease,
particularly the importance of voice use to the indi-
vidual’s occupational and social involvement and
self-image.
As conﬁrmed with input from focus groups of
patients with LPR, the greatest HRQL impact of
LPR is in the area of social functioning, though
psychological and emotional well-being and role
performance are also signiﬁcantly affected. It is
important that these domains be integral to any new
HRQL measure for LPR.
The development of a new measure to assess the
comprehensive impact of LPR on patient HRQL
will help to increase awareness within the medical
community of the burden of LPR and can contrib-
ute to the appropriate evaluation of new and exist-
ing therapies and patient management strategies.
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